Institutional Biosafety Committee

The NKU Institutional Biosafety Committee (IBC) must conduct a review of projects that fall into certain categories as outlined in the Biohazard Agent Registration (BAR) form. 

A BAR form must be completed for studies that fall into any of the categories below:

1. Construction and/or use of recombinant DNA, beyond accepted/standard (non-hazardous) practices, in standard host-vector systems
   
   
2. Toxins or infectious agents requiring handling conditions above Biosafety Level-1. (Biosafety Level determinations are outlined by the CDC publication Biosafety in Microbiological and Biomedical Laboratories.)

If there is a question as to whether or not the activity requires IBC review, the researcher should submit a description of the activity to the IBC Chair or IBC Administrator for final determination.

This summary should include:

1. Summary of the study
2. Amount of agent/drug to be used
3. Condition of use of agent/drug
4. Inactivation and disposal of agent/drug

Joe Mester, Ph.D.
IBC Chair
IBC Term: 05/01/2018 - 04/30/2021

Mark Bardgett, Ph.D.
Faculty Member Representative
IBC Term: 06/01/2017 - 05/31/2020

Audra Points, B.S.
Environmental Health/Safety Department Representative
IBC Term: 10/1/2019 – 09/30/2022

Madeline Blevins, B.S.
Lab Technician
IBC Term: 06/15/2018 - 06/14/2021

Michael Ware, Ph.D.
Genera Public Representative
IBC Term: 01/01/2020 – 12-31-2022

Michael Guy, Ph.D.
Scientist
IBC Term: 09/09/2019 – 09/08/2022

Sabine Zacate, Ph.D.
General Public Representative
IBC Term: 05/02/2017 - 05/01/2020